Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical characteristics of Kawasaki disease with sterile pyuria

  • Choi, Ja Yun (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Park, Sun Young (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Choi, Kwang Hae (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Park, Yong Hoon (Department of Pediatrics, Yeungnam University College of Medicine) ;
  • Lee, Young Hwan (Department of Pediatrics, Yeungnam University College of Medicine)
  • Received : 2011.09.14
  • Accepted : 2012.10.19
  • Published : 2013.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Kawasaki disease (KD) is a systemic vasculitis and affects many organ systems. It often presents sterile pyuria, microscopic hematuria, and proteinuria due to renal involvement. The aims of this study were to define clinical characteristics of acute KD patients with pyuria and to analyze meaning of pyuria in KD. Methods: The medical records and laboratory findings including serum and urine test of 133 patients with KD admitted to Yeungnam University Hospital from March 2006 to December 2010 were reviewed retrospectively. Results: Forty patients had sterile pyuria and their clinical characteristics including age, gender and body weight were not significantly different with those who did not have pyuria. Fever duration after treatment was significantly longer in KD patients with pyuria. Erythrocyte sedimentation rate, C-reactive protein and serum concentration of alanine aminotransferase were significantly higher in patients with pyuria. Hyponatremia and coronary artery lesion were seen more often in patients with pyuria but there was no significant difference. Also serum blood urea nitrogen was significantly higher in KD patients with pyuria. Urine ${\beta}_2$-microglobulin was elevated in both patients groups and showed no difference between two groups. Conclusion: We found more severe inflammatory reaction in KD patients with pyuria. We also found elevation of some useful parameters like ${\beta}_2$-microglobulin that indicate renal involvement of KD through the urine test. Careful management and follow up will need for KD patients with pyuria and it is necessary in the future to study the specific parameters for renal involvement of KD.

Keywords

References

  1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
  2. Leung DY, Siegel RL, Grady S, Krensky A, Meade R, Reinherz EL, et al. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin Immunol Immunopathol 1982;23:100-12. https://doi.org/10.1016/0090-1229(82)90075-7
  3. Furukawa S, Matsubara T, Motohashi T, Tsuda M, Sugimoto H, Yabuta K. Immunological abnormalities in Kawasaki disease with coronary artery lesions. Acta Paediatr Jpn 1991;33:745-51. https://doi.org/10.1111/j.1442-200X.1991.tb02603.x
  4. de Inocencio J, Hirsch R. The role of T cells in Kawasaki disease. Crit Rev Immunol 1995;15:349-57. https://doi.org/10.1615/CritRevImmunol.v15.i3-4.80
  5. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976;130:599-607.
  6. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 2000;154:453-6. https://doi.org/10.1001/archpedi.154.5.453
  7. Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol 2006;21:778-81. https://doi.org/10.1007/s00467-006-0086-6
  8. Wirojanan J, Sopontammarak S, Vachvanichsanong P. Sterile pyuria in Kawasaki disease. Pediatr Nephrol 2004;19:363. https://doi.org/10.1007/s00467-003-1394-8
  9. Mac Ardle BM, Chambers TL, Weller SD, Tribe CR. Acute renal failure in Kawasaki disease. J R Soc Med 1983;76:615-6.
  10. Salcedo JR, Greenberg L, Kapur S. Renal histology of mucocutaneous lymph node syndrome (Kawasaki disease). Clin Nephrol 1988;29:47-51.
  11. Veiga PA, Pieroni D, Baier W, Feld LG. Association of Kawasaki disease and interstitial nephritis. Pediatr Nephrol 1992;6:421-3. https://doi.org/10.1007/BF00873999
  12. Bonany PJ, Bilkis MD, Gallo G, Lago N, Dennehy MV, Sosa del Valle JM, et al. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol 2002;17:329-31. https://doi.org/10.1007/s00467-002-0844-z
  13. Nardi PM, Haller JO, Friedman AP, Slovis TL, Schaffer RM. Renal manifestations of Kawasaki's disease. Pediatr Radiol 1985;15:116-8. https://doi.org/10.1007/BF02388716
  14. Lande MB, Gleeson JG, Sundel RP. Kawasaki disease and acute renal failure. Pediatr Nephrol 1993;7:593. https://doi.org/10.1007/BF00852560
  15. Senzaki H, Suda M, Noma S, Kawaguchi H, Sakakihara Y, Hishi T. Acute heart failure and acute renal failure in Kawasaki disease. Acta Paediatr Jpn 1994;36:443-7. https://doi.org/10.1111/j.1442-200X.1994.tb03220.x
  16. Ferriero DM, Wolfsdorf JI. Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics 1981;68:405-6.
  17. Heldrich FJ, Jodorkovsky RA, Lake AM, Parnes CA. Kawasaki syndrome: HUS and HSP complicating its course and management. Md Med J 1987;36:764-6.
  18. Lee BW, Yap HK, Yip WC, Giam YC, Tay JS. Nephrotic syndrome in Kawasaki disease. Aust Paediatr J 1989;25:241-2.
  19. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. https://doi.org/10.1542/peds.2004-2182
  20. Guignard JP, Santos F. Laboratory investigations. In: Avner ED, Harmon WE, Niaudet P, editors. Pediatric nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2004:399-424.
  21. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984;104:849-54. https://doi.org/10.1016/S0022-3476(84)80479-5
  22. Uehara R, Yashiro M, Hayasaka S, Oki I, Nakamura Y, Muta H, et al. Serum alanine aminotransferase concentrations in patients with Kawasaki disease. Pediatr Infect Dis J 2003;22:839-42. https://doi.org/10.1097/01.inf.0000086388.74930.0d
  23. Uchida K, Gotoh A. Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 2002;323:121-8. https://doi.org/10.1016/S0009-8981(02)00177-8
  24. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-8. https://doi.org/10.1038/ki.1995.40
  25. Zahran A, El-Husseini A, Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol 2007;27:197-205. https://doi.org/10.1159/000100907
  26. Macdonald J, Marcora S, Jibani M, Roberts G, Kumwenda M, Glover R, et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 2006;48:712-9. https://doi.org/10.1053/j.ajkd.2006.07.001
  27. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-21. https://doi.org/10.1111/j.1523-1755.2004.00517.x
  28. Bolignano D, Donato V, Coppolino G, Campo S, Buemi A, Lacquaniti A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis 2008;52:595-605. https://doi.org/10.1053/j.ajkd.2008.01.020
  29. Endre ZH, Westhuyzen J. Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton) 2008;13:91-8. https://doi.org/10.1111/j.1440-1797.2007.00905.x
  30. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007;212:209-17. https://doi.org/10.1002/path.2175
  31. Berggard I, Bearn AG. Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem 1968;243:4095-103.
  32. Rosner MH, Bolton WK. Renal function testing. Am J Kidney Dis 2006; 47:174-83. https://doi.org/10.1053/j.ajkd.2005.08.038
  33. Tack ED, Perlman JM, Robson AM. Renal injury in sick newborn infants: a prospective evaluation using urinary beta 2- microglobulin concentrations. Pediatrics 1988;81:432-40.
  34. Schentag JJ, Plaut ME. Patterns of urinary beta 2-microglobulin excretion by patients treated with aminoglycosides. Kidney Int 1980;17:654-61. https://doi.org/10.1038/ki.1980.77
  35. Ohta K, Seno A, Shintani N, Kato E, Yachie A, Seki H, et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 1993;152:647-9. https://doi.org/10.1007/BF01955240
  36. Wang JN, Chiou YY, Chiu NT, Chen MJ, Lee BF, Wu JM. Renal scarring sequelae in childhood Kawasaki disease. Pediatr Nephrol 2007;22:684-9. https://doi.org/10.1007/s00467-006-0385-y

Cited by

  1. Renal Manifestations and Imaging Studies of Kawasaki Disease vol.17, pp.2, 2013, https://doi.org/10.3339/jkspn.2013.17.2.86
  2. Paraclinical Evolutions Regarding Liver and Renal Abnormalities of Kawasaki Disease in the Southeast of Iran vol.5, pp.1, 2014, https://doi.org/10.17795/compreped-15777
  3. Kawasaki Disease: Paraclinical Evolution and Clinical Outcomes of Iranian Patients vol.5, pp.3, 2013, https://doi.org/10.17795/compreped-19929
  4. Sterile Pyuria vol.372, pp.11, 2013, https://doi.org/10.1056/nejmra1410052
  5. Pyuria in patients with Kawasaki disease vol.4, pp.2, 2013, https://doi.org/10.5409/wjcp.v4.i2.25
  6. 농뇨 동반 가와사키병의 임상적 특징 vol.24, pp.3, 2017, https://doi.org/10.14776/piv.2017.24.3.141
  7. Controversies in diagnosis and management of Kawasaki disease vol.7, pp.1, 2013, https://doi.org/10.5409/wjcp.v7.i1.27
  8. Early features of Kawasaki disease with pyuria in febrile infants younger than 6 months vol.18, pp.1, 2013, https://doi.org/10.1186/s12887-018-1362-x
  9. Differentiating Kawasaki disease from urinary tract infection in febrile children with pyuria and C-reactive protein elevation vol.44, pp.1, 2018, https://doi.org/10.1186/s13052-018-0585-7
  10. Kawasaki disease: characteristics, diagnosis, and unusual presentations vol.15, pp.10, 2019, https://doi.org/10.1080/1744666x.2019.1659726
  11. Profile of Urinary Cytokines in Kawasaki Disease: Non-Invasive Markers vol.11, pp.10, 2013, https://doi.org/10.3390/diagnostics11101857